Driven by Our Promise
It began with a promise. CSL Vifor's parent company, CSL, was formed more than 100 years ago to save lives using the latest technologies. In the century since, CSL has grown into a global biotechnology leader, driven by that same promise to save and improve lives. CSL offers the broadest range of quality plasma-derived and recombinant therapies in our industry. CSL ability to innovate and deliver life-saving medicines for patients with rare disease, iron deficiency, nephrology and other unmet medical needs around the world has earned us a reputation for always putting patients first. We are CSL Vifor and we are driven by our promise.
For further information on our parent company and investing with us, visit CSL.com.
Focus on Iron deficiency & Nephrology
CSL Vifor is a global partner of choice for pharmaceuticals and innovative, leading therapies in iron deficiency and nephrology. We specialise in strategic global partnering, in-licensing and developing, manufacturing and marketing pharmaceutical products for precision healthcare, aiming to help patients around the world lead better, healthier lives. Headquartered in St. Gallen, Switzerland, CSL Vifor also includes the joint company Vifor Fresenius Medical Care Renal Pharma (with Fresenius Medical Care).